{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative adjective directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_19328", "batch_size": 200, "batch_pos": 81, "statement_text": "Funds from the U.S. Biomedical Advanced Research and Development Authority will be used to complete late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "The segment describes vaccine development using neutral language.", "method": "llm_batch", "batch_id": "batch_2_12484", "batch_size": 200, "batch_pos": 39, "statement_text": "Funds from the U.S. Biomedical Advanced Research and Development Authority will be used to complete late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "'will be used' and 'complete' are not moderate verbs.", "method": "llm_batch", "batch_id": "batch_3_15572", "batch_size": 200, "batch_pos": 166, "statement_text": "Funds from the U.S. Biomedical Advanced Research and Development Authority will be used to complete late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza.", "article_id": 1745}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_14748", "batch_size": 200, "batch_pos": 163, "statement_text": "Funds from the U.S. Biomedical Advanced Research and Development Authority will be used to complete late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza.", "article_id": 1745}
{"Q": 5, "answer": "no", "rationale": "The segment reports use of funds without explicit calming cues.", "method": "llm_batch", "batch_id": "batch_5_9684", "batch_size": 200, "batch_pos": 158, "statement_text": "Funds from the U.S. Biomedical Advanced Research and Development Authority will be used to complete late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza.", "article_id": 1745}
{"Q": 6, "answer": "no", "rationale": "The segment does not contain a minimiser combined with a scale contrast.", "method": "llm_batch", "batch_id": "batch_6_18736", "batch_size": 200, "batch_pos": 111, "statement_text": "Funds from the U.S. Biomedical Advanced Research and Development Authority will be used to complete late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza.", "article_id": 1745}
{"Q": 7, "answer": "no", "rationale": "Segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_17672", "batch_size": 200, "batch_pos": 103, "statement_text": "Funds from the U.S. Biomedical Advanced Research and Development Authority will be used to complete late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza.", "article_id": 1745}
{"Q": 8, "answer": "yes", "rationale": "Describes use of funds for development/testing ('will be used to complete late-stage development and testing') without calming keywords.", "method": "llm_batch", "batch_id": "batch_8_17320", "batch_size": 200, "batch_pos": 132, "statement_text": "Funds from the U.S. Biomedical Advanced Research and Development Authority will be used to complete late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza.", "article_id": 1745}
